Series B - RubiconMD

Series B - RubiconMD

Investment Firm

Overview

RubiconMD empowers and innovates for primary care by democratizing medical expertise.

Announced Date

Apr 19, 2018

Funding Type

Series B

Highlights

Location

New York, New York, United States, North America

Social

Investor Lead

HLM Venture Partners

HLM Venture Partners

HLM Venture Partners is a debt and early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorAlma Mundi Ventures
Participant InvestorTau Ventures
Participant InvestorHLM Venture Partners
Participant InvestorCentene
Participant InvestorParameter Ventures

Round Details and Background

RubiconMD raised $13800000 on 2018-04-19 in Series B

RubiconMD empowers and innovates for primary care by democratizing medical expertise.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2014
Pre Seed Round - RubiconMD
1-20.0K
Sep 22, 2016
Venture Round - RubiconMD
1-750.0K
Jun 01, 2016
Series A - RubiconMD
5-4.0M
Dec 22, 2014
Seed Round - RubiconMD
2-1.3M

Recent Activity

There is no recent news or activity for this profile.